Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-018-1932-x.

Title:
Current state of Alzheimer’s fluid biomarkers | Acta Neuropathologica
Description:
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinical trials. Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment. Biomarkers used in drug development programmes should be qualified for a specific context of use (COU). These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization. The core AD CSF biomarkers Aβ42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clinical trials. However, there is a need to better understand their potential for other COUs, as well as identify additional fluid biomarkers reflecting other aspects of AD pathophysiology. Several novel fluid biomarkers have been proposed, but their role in AD pathology and their use as AD biomarkers have yet to be validated. In this review, we summarize some of the pathological mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, α-synuclein, TDP-43, ferritin, VILIP-1, and NF-L) associated with each mechanism. We discuss the potential COUs for each biomarker.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

pubmed, article, google, scholar, alzheimers, disease, cas, csf, central, biomarkers, fluid, levels, tau, cerebrospinal, patients, plasma, biomarker, protein, study, neurol, cognitive, brain, amyloid, clinical, studies, research, blennow, mci, pathology, αsynuclein, dementia, zetterberg, diagnosis, dis, httpsdoiorgs, neurodegenerative, potential, controls, early, increased, found, alzheimer, dement, diseases, ttau, bace, synaptic, subjects, impairment, httpsdoiorgjad,

Topics {✒️}

eu/docs/en_gb/document_library/regulatory_and_procedural_guideline/2011/12/wc500118365 eu/docs/en_gb/document_library/scientific_guideline/2018/02/wc500244609 gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm267449 gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm596728 int/mediacentre/factsheets/fs362/en/ cerebro-spinal-fluid related biomarkers c-terminally truncated alpha-synuclein storage-dependent pre-analytical variability article download pdf amyloid-β-induced cell death alpha-synuclein oligomers-neurotoxic molecules n-methyl-d-aspartate cerebrospinal fluid tau/β-amyloid mismatch—high p-tau accompanied tnf-α converting enzyme α-synuclein pathology α-synuclein single-molecule fluorescence microscopy n-truncated abeta peptides quantitative susceptibility mapping clinical alzheimer’s-type dementia csf aβ1-42/aβ1-40 ratio cerebrospinal fluid aβeta42/aβeta40 transforming growth factor-β hypoxia/ischemia activate processing biomarker-guided classification system tumour necrosis factor evaluating amyloid-β oligomers phospho-tau/total tau ratio alpha-synuclein rt-quic increased protein-conjugated acrolein cerebrospinal fluid amyloid-β biomarker-guided classification scheme standardize csf pre-analytics amyloid-β degradation pattern post-translationally modified fragments pathological α-synuclein exacerbates relapsing-remitting multiple sclerosis csf pre-analytics consortium jack cr jr aβ-plaque deposition equivalent fluid-based surrogate biomarkers fluid-based α-synuclein circulating brain-enriched micrornas facilitate pre-symptomatic diagnosis accurately predict aβ-positivity end-specific aβ monoclonals ante-mortem cognitive status remaining pre-analytical factors mass-spectrometry-based method natalizumab-treated multiple sclerosis

Questions {❓}

  • Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F (2013) Amylin deposition in the brain: a second amyloid in Alzheimer disease?
  • Steardo L Jr, Bronzuoli MR, Iacomino A, Esposito G, Steardo L, Scuderi C (2015) Does neuroinflammation turn on the flame in Alzheimer’s disease?
  • Willemse E, van Uffelen K, Brix B, Engelborghs S, Vanderstichele H, Teunissen C (2017) How to handle adsorption of cerebrospinal fluid amyloid β (1-42) in laboratory practice?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Current state of Alzheimer’s fluid biomarkers
         description:Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinical trials. Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment. Biomarkers used in drug development programmes should be qualified for a specific context of use (COU). These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization. The core AD CSF biomarkers Aβ42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clinical trials. However, there is a need to better understand their potential for other COUs, as well as identify additional fluid biomarkers reflecting other aspects of AD pathophysiology. Several novel fluid biomarkers have been proposed, but their role in AD pathology and their use as AD biomarkers have yet to be validated. In this review, we summarize some of the pathological mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, α-synuclein, TDP-43, ferritin, VILIP-1, and NF-L) associated with each mechanism. We discuss the potential COUs for each biomarker.
         datePublished:2018-11-28T00:00:00Z
         dateModified:2018-11-28T00:00:00Z
         pageStart:821
         pageEnd:853
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00401-018-1932-x
         keywords:
            Alzheimer’s disease
            Amyloid
            Biomarker
            Blood
            Cerebrospinal fluid
            Tau
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-018-1932-x/MediaObjects/401_2018_1932_Fig1_HTML.png
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:136
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:José Luis Molinuevo
               affiliation:
                     name:Universitat Pompeu Fabra
                     address:
                        name:BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Hospital Clinic-IDIBAPS
                     address:
                        name:Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Scott Ayton
               affiliation:
                     name:University of Melbourne
                     address:
                        name:Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Richard Batrla
               affiliation:
                     name:Roche Diagnostics International
                     address:
                        name:Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin M. Bednar
               affiliation:
                     name:Takeda Development Centre Americas Ltd
                     address:
                        name:Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tobias Bittner
               affiliation:
                     name:Genentech, A Member of the Roche Group
                     address:
                        name:Genentech, A Member of the Roche Group, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey Cummings
               affiliation:
                     name:Cleveland Clinic Lou Ruvo Center for Brain Health
                     address:
                        name:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anne M. Fagan
               affiliation:
                     name:Washington University in St. Louis
                     address:
                        name:Department of Neurology, Washington University in St. Louis, St. Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Harald Hampel
               affiliation:
                     name:AXA Research Fund and Sorbonne University Chair
                     address:
                        name:AXA Research Fund and Sorbonne University Chair, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital
                     address:
                        name:Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225
                     address:
                        name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Pitié-Salpêtrière Hospital, AP-HP
                     address:
                        name:Department of Neurology, Institute of Memory and Alzheimer’s Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michelle M. Mielke
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alvydas Mikulskis
               affiliation:
                     name:Biomarkers, Biogen
                     address:
                        name:Biomarkers, Biogen, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sid O’Bryant
               affiliation:
                     name:University of North Texas Health Science Center
                     address:
                        name:Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Philip Scheltens
               affiliation:
                     name:VU University Medical Center
                     address:
                        name:Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey Sevigny
               affiliation:
                     name:F. Hoffmann-La Roche
                     address:
                        name:Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Leslie M. Shaw
               affiliation:
                     name:University of Pennsylvania
                     address:
                        name:Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Holly D. Soares
               affiliation:
                     name:Clinical Development Neurology, AbbVie
                     address:
                        name:Clinical Development Neurology, AbbVie, North Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gary Tong
               affiliation:
                     name:Lundbeck
                     address:
                        name:Lundbeck, Deerfield, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Q. Trojanowski
               affiliation:
                     name:Perelman School of Medicine at the University of Pennsylvania
                     address:
                        name:Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henrik Zetterberg
               affiliation:
                     name:The Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska University Hospital
                     address:
                        name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UK Dementia Research Institute at UCL
                     address:
                        name:UK Dementia Research Institute at UCL, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaj Blennow
               affiliation:
                     name:The Sahlgrenska Academy at the University of Gothenburg
                     address:
                        name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Sahlgrenska University Hospital
                     address:
                        name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Current state of Alzheimer’s fluid biomarkers
      description:Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiology. The number of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clinical trials. Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment. Biomarkers used in drug development programmes should be qualified for a specific context of use (COU). These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization. The core AD CSF biomarkers Aβ42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clinical trials. However, there is a need to better understand their potential for other COUs, as well as identify additional fluid biomarkers reflecting other aspects of AD pathophysiology. Several novel fluid biomarkers have been proposed, but their role in AD pathology and their use as AD biomarkers have yet to be validated. In this review, we summarize some of the pathological mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, α-synuclein, TDP-43, ferritin, VILIP-1, and NF-L) associated with each mechanism. We discuss the potential COUs for each biomarker.
      datePublished:2018-11-28T00:00:00Z
      dateModified:2018-11-28T00:00:00Z
      pageStart:821
      pageEnd:853
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00401-018-1932-x
      keywords:
         Alzheimer’s disease
         Amyloid
         Biomarker
         Blood
         Cerebrospinal fluid
         Tau
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-018-1932-x/MediaObjects/401_2018_1932_Fig1_HTML.png
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:136
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:José Luis Molinuevo
            affiliation:
                  name:Universitat Pompeu Fabra
                  address:
                     name:BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Hospital Clinic-IDIBAPS
                  address:
                     name:Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Scott Ayton
            affiliation:
                  name:University of Melbourne
                  address:
                     name:Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Richard Batrla
            affiliation:
                  name:Roche Diagnostics International
                  address:
                     name:Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin M. Bednar
            affiliation:
                  name:Takeda Development Centre Americas Ltd
                  address:
                     name:Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tobias Bittner
            affiliation:
                  name:Genentech, A Member of the Roche Group
                  address:
                     name:Genentech, A Member of the Roche Group, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey Cummings
            affiliation:
                  name:Cleveland Clinic Lou Ruvo Center for Brain Health
                  address:
                     name:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anne M. Fagan
            affiliation:
                  name:Washington University in St. Louis
                  address:
                     name:Department of Neurology, Washington University in St. Louis, St. Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Harald Hampel
            affiliation:
                  name:AXA Research Fund and Sorbonne University Chair
                  address:
                     name:AXA Research Fund and Sorbonne University Chair, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital
                  address:
                     name:Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225
                  address:
                     name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Pitié-Salpêtrière Hospital, AP-HP
                  address:
                     name:Department of Neurology, Institute of Memory and Alzheimer’s Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michelle M. Mielke
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alvydas Mikulskis
            affiliation:
                  name:Biomarkers, Biogen
                  address:
                     name:Biomarkers, Biogen, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sid O’Bryant
            affiliation:
                  name:University of North Texas Health Science Center
                  address:
                     name:Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Philip Scheltens
            affiliation:
                  name:VU University Medical Center
                  address:
                     name:Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey Sevigny
            affiliation:
                  name:F. Hoffmann-La Roche
                  address:
                     name:Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Leslie M. Shaw
            affiliation:
                  name:University of Pennsylvania
                  address:
                     name:Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Holly D. Soares
            affiliation:
                  name:Clinical Development Neurology, AbbVie
                  address:
                     name:Clinical Development Neurology, AbbVie, North Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gary Tong
            affiliation:
                  name:Lundbeck
                  address:
                     name:Lundbeck, Deerfield, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Q. Trojanowski
            affiliation:
                  name:Perelman School of Medicine at the University of Pennsylvania
                  address:
                     name:Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henrik Zetterberg
            affiliation:
                  name:The Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska University Hospital
                  address:
                     name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UK Dementia Research Institute at UCL
                  address:
                     name:UK Dementia Research Institute at UCL, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaj Blennow
            affiliation:
                  name:The Sahlgrenska Academy at the University of Gothenburg
                  address:
                     name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Sahlgrenska University Hospital
                  address:
                     name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:136
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Universitat Pompeu Fabra
      address:
         name:BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain
         type:PostalAddress
      name:Hospital Clinic-IDIBAPS
      address:
         name:Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain
         type:PostalAddress
      name:University of Melbourne
      address:
         name:Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
         type:PostalAddress
      name:Roche Diagnostics International
      address:
         name:Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland
         type:PostalAddress
      name:Takeda Development Centre Americas Ltd
      address:
         name:Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, USA
         type:PostalAddress
      name:Genentech, A Member of the Roche Group
      address:
         name:Genentech, A Member of the Roche Group, Basel, Switzerland
         type:PostalAddress
      name:Cleveland Clinic Lou Ruvo Center for Brain Health
      address:
         name:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA
         type:PostalAddress
      name:Washington University in St. Louis
      address:
         name:Department of Neurology, Washington University in St. Louis, St. Louis, USA
         type:PostalAddress
      name:AXA Research Fund and Sorbonne University Chair
      address:
         name:AXA Research Fund and Sorbonne University Chair, Paris, France
         type:PostalAddress
      name:Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital
      address:
         name:Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France
         type:PostalAddress
      name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225
      address:
         name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France
         type:PostalAddress
      name:Pitié-Salpêtrière Hospital, AP-HP
      address:
         name:Department of Neurology, Institute of Memory and Alzheimer’s Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:Biomarkers, Biogen
      address:
         name:Biomarkers, Biogen, Cambridge, USA
         type:PostalAddress
      name:University of North Texas Health Science Center
      address:
         name:Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, USA
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:F. Hoffmann-La Roche
      address:
         name:Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
         type:PostalAddress
      name:University of Pennsylvania
      address:
         name:Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:Clinical Development Neurology, AbbVie
      address:
         name:Clinical Development Neurology, AbbVie, North Chicago, USA
         type:PostalAddress
      name:Lundbeck
      address:
         name:Lundbeck, Deerfield, USA
         type:PostalAddress
      name:Perelman School of Medicine at the University of Pennsylvania
      address:
         name:Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:The Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UK Dementia Research Institute at UCL
      address:
         name:UK Dementia Research Institute at UCL, London, UK
         type:PostalAddress
      name:The Sahlgrenska Academy at the University of Gothenburg
      address:
         name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
         type:PostalAddress
      name:Sahlgrenska University Hospital
      address:
         name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:José Luis Molinuevo
      affiliation:
            name:Universitat Pompeu Fabra
            address:
               name:BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Hospital Clinic-IDIBAPS
            address:
               name:Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Scott Ayton
      affiliation:
            name:University of Melbourne
            address:
               name:Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
               type:PostalAddress
            type:Organization
      name:Richard Batrla
      affiliation:
            name:Roche Diagnostics International
            address:
               name:Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland
               type:PostalAddress
            type:Organization
      name:Martin M. Bednar
      affiliation:
            name:Takeda Development Centre Americas Ltd
            address:
               name:Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Tobias Bittner
      affiliation:
            name:Genentech, A Member of the Roche Group
            address:
               name:Genentech, A Member of the Roche Group, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Jeffrey Cummings
      affiliation:
            name:Cleveland Clinic Lou Ruvo Center for Brain Health
            address:
               name:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA
               type:PostalAddress
            type:Organization
      name:Anne M. Fagan
      affiliation:
            name:Washington University in St. Louis
            address:
               name:Department of Neurology, Washington University in St. Louis, St. Louis, USA
               type:PostalAddress
            type:Organization
      name:Harald Hampel
      affiliation:
            name:AXA Research Fund and Sorbonne University Chair
            address:
               name:AXA Research Fund and Sorbonne University Chair, Paris, France
               type:PostalAddress
            type:Organization
            name:Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital
            address:
               name:Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France
               type:PostalAddress
            type:Organization
            name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225
            address:
               name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France
               type:PostalAddress
            type:Organization
            name:Pitié-Salpêtrière Hospital, AP-HP
            address:
               name:Department of Neurology, Institute of Memory and Alzheimer’s Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France
               type:PostalAddress
            type:Organization
      name:Michelle M. Mielke
      affiliation:
            name:Mayo Clinic
            address:
               name:Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Alvydas Mikulskis
      affiliation:
            name:Biomarkers, Biogen
            address:
               name:Biomarkers, Biogen, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Sid O’Bryant
      affiliation:
            name:University of North Texas Health Science Center
            address:
               name:Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, USA
               type:PostalAddress
            type:Organization
      name:Philip Scheltens
      affiliation:
            name:VU University Medical Center
            address:
               name:Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Jeffrey Sevigny
      affiliation:
            name:F. Hoffmann-La Roche
            address:
               name:Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Leslie M. Shaw
      affiliation:
            name:University of Pennsylvania
            address:
               name:Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Holly D. Soares
      affiliation:
            name:Clinical Development Neurology, AbbVie
            address:
               name:Clinical Development Neurology, AbbVie, North Chicago, USA
               type:PostalAddress
            type:Organization
      name:Gary Tong
      affiliation:
            name:Lundbeck
            address:
               name:Lundbeck, Deerfield, USA
               type:PostalAddress
            type:Organization
      name:John Q. Trojanowski
      affiliation:
            name:Perelman School of Medicine at the University of Pennsylvania
            address:
               name:Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Henrik Zetterberg
      affiliation:
            name:The Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska University Hospital
            address:
               name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:UCL Institute of Neurology
            address:
               name:Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
            name:UK Dementia Research Institute at UCL
            address:
               name:UK Dementia Research Institute at UCL, London, UK
               type:PostalAddress
            type:Organization
      name:Kaj Blennow
      affiliation:
            name:The Sahlgrenska Academy at the University of Gothenburg
            address:
               name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
               type:PostalAddress
            type:Organization
            name:Sahlgrenska University Hospital
            address:
               name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Universitat Pompeu Fabra, Barcelona, Spain
      name:Unidad de Alzheimer y otros trastornos cognitivos, Hospital Clinic-IDIBAPS, Barcelona, Spain
      name:Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia
      name:Roche Centralised and Point of Care Solutions, Roche Diagnostics International, Rotkreuz, Switzerland
      name:Neuroscience Therapeutic Area Unit, Takeda Development Centre Americas Ltd, Cambridge, USA
      name:Genentech, A Member of the Roche Group, Basel, Switzerland
      name:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA
      name:Department of Neurology, Washington University in St. Louis, St. Louis, USA
      name:AXA Research Fund and Sorbonne University Chair, Paris, France
      name:Sorbonne University, GRC No 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France
      name:Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France
      name:Department of Neurology, Institute of Memory and Alzheimer’s Disease (IM2A), Pitié-Salpêtrière Hospital, AP-HP, Paris, France
      name:Departments of Epidemiology and Neurology, Mayo Clinic, Rochester, USA
      name:Biomarkers, Biogen, Cambridge, USA
      name:Department of Pharmacology and Neuroscience; Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, USA
      name:Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
      name:Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
      name:Department of Pathology and Laboratory Medicine, and Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, USA
      name:Clinical Development Neurology, AbbVie, North Chicago, USA
      name:Lundbeck, Deerfield, USA
      name:Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
      name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden
      name:Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
      name:UK Dementia Research Institute at UCL, London, UK
      name:Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
      name:Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal Campus, Sahlgrenska University Hospital, Mölndal, Sweden

External Links {🔗}(1692)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Cash.js
  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

8.28s.